|

Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation

RECRUITINGSponsored by University of Edinburgh
Actively Recruiting
SponsorUniversity of Edinburgh
Started2024-01-24
Est. completion2032-01
Eligibility
Age16 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06234410

Summary

Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation. Current strategies to assess patient's cardiovascular risk prior to kidney transplantation do not identify those at highest risk and do not improve outcomes. This study will use a heart scan known as computed tomography coronary angiography (CTCA) to see whether this scan can identify patients at highest risk of future cardiovascular disease prior to transplantation. Studies have shown it is able to do this in patients with normal kidney function. The aim of this study is to develop CTCA as an effective tool to risk stratify patients prior to kidney transplantation.

Eligibility

Age: 16 Years+Healthy volunteers accepted
Inclusion Criteria:

* Has kidney failure and is on the waitlist for a kidney transplant
* Age 16 years and over
* Able to give informed consent

Exclusion Criteria:

* Contraindication to CT scanning, including contrast allergy
* Patients being considered for a simultaneous kidney-pancreas, kidney-liver and/or kidney-islet transplantation
* Inability to give informed consent

Conditions3

Cardiovascular DiseasesHeart DiseaseKidney Transplant; Complications

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.